<DOC>
	<DOCNO>NCT00579475</DOCNO>
	<brief_summary>Uterine fibroid benign common condition among woman reproductive age . It one common reason hysterectomy since often cause bleed problem sometimes lead anemia . Several alternative treatment regimen investigate could replace surgery . The antiprogesterone , mifepristone , one promising drug test . In addition inhibit effect growth uterine fibroid antiprogestins propose antiproliferative effect breast tissue . The purpose present study evaluate effect mifepristone volume uterine fibroid . The study also address effect mifepristone breast tissue</brief_summary>
	<brief_title>The Effect Mifepristone Uterine Fibroids Breast Tissue</brief_title>
	<detailed_description>Other purpose study include : - To develop new non-surgical method treatment uterine fibroid - To study effect mifepristone size uterine fibroid - To evaluate factor regulate fibroid growth comparison untreated fibroid normal myometrium - To study effect mifepristone amount blood loss pelvic pain patient fibroids - To study effect mifepristone proliferation breast tissue</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Uterine fibroid require treatment Good general health Willing able participate give informed consent Need immediate surgery Concomitant hormonal treatment ( HRT ) History malignant disorder breast Any contraindication mifepristone Criteria retrospective exclusion : Subjects may exclude analysis one follow applies : Any violation study protocol Lack essential data</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>mifepristone</keyword>
	<keyword>leiomyoma</keyword>
	<keyword>breast epithelial cell proliferation</keyword>
</DOC>